Medexus Pharmaceuticals Inc. announced the appointment of Marcel Konrad as Chief Financial Officer of the Company, effective immediately. Mr. Konrad succeeds Roland Boivin, who is stepping down after nearly a decade in the role. Mr. Boivin has agreed to stay on in an advisory capacity in order to help ensure an orderly transition of responsibilities to Mr. Konrad over the next approximately three months. Prior to joining CareDx Inc., Mr. Konrad worked in similar roles at Santen Inc., a US subsidiary of a publicly listed Japanese pharmaceutical company with global operations, and held various roles at Novartis Pharmaceuticals, both in the US and Switzerland. Mr. Konrad holds an International MBA from the University of San Diego and graduated Business Administration from HEC Lausanne, University of Lausanne, Switzerland.